We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It.
From silent symptoms to fibrotic complications, it’s time to speak up and be heard.
🔗 Discover the campaign: efcca.org/worldibdday2025
On #WorldIBDDay, we join #EFCCA ´s call to break the taboo and silence around #IBD.
🌎Over 10M people live with it worldwide — yet shame, taboo, and silence still persist.
💬Let’s talk about it.
+ info 🔗 efcca.org/worldibdday2...
On #WorldIBDDay, we join #EFCCA ´s call to break the taboo and silence around #IBD.
🌎Over 10M people live with it worldwide — yet shame, taboo, and silence still persist.
💬Let’s talk about it.
+ info 🔗 efcca.org/worldibdday2...
Tras la Asamblea General celebrada el pasado 31 de mayo en Bruselas, EFCCA da paso a un nuevo capítulo como Federación Internacional de Asociaciones de Crohn y Colitis (IFCCA).
Este cambio histórico refleja el crecimiento global de nuestra comunidad.
#IFCCA #ACCU
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials.
➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
#IFCCA (ex-EFCCA) dont @afacrohnrch.bsky.social est membre est fière d'y avoir participé.
💜 ça avance ! #IBD #Crohn #RCH #Colitis
article in english=> buff.ly/bFZw5ss 📄
#IFCCA (ex-EFCCA) dont @afacrohnrch.bsky.social est membre est fière d'y avoir participé.
💜 ça avance ! #IBD #Crohn #RCH #Colitis
article in english=> buff.ly/bFZw5ss 📄
Check out the factsheets here!➡️[https://loom.ly/yW8mEBc]
#IBD #FIBROTARGET
Check out the factsheets here!➡️[https://loom.ly/yW8mEBc]
#IBD #FIBROTARGET
📷: La Opinión de Málaga, Archivo personal Bettina Duarte y Archivo ACCU Málaga.
🗓️ 6 Feb 2025: webinar with EFCCA, patient representatives and experts from
@fibrotarget.bsky.social!
Join us to learn more about living with fibrosis and future innovations in fibrosis and fibrostenosis research!
🕠 17:30-18:30 CET
💻 Register➡️ loom.ly/6WdjxOY
🗓️ 6 Feb 2025: webinar with EFCCA, patient representatives and experts from
@fibrotarget.bsky.social!
Join us to learn more about living with fibrosis and future innovations in fibrosis and fibrostenosis research!
🕠 17:30-18:30 CET
💻 Register➡️ loom.ly/6WdjxOY
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY
🗓️ 6 Feb 2025
🕠 17:30-18:30 CET
💻 Online
Register here➡️ loom.ly/6WdjxOY
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Join the EFCCA talks webinar on "Living with fibrosis: Challenges, Treatments and Innovations"!
📲Follow the webinar LIVE at the following links:
➡️ Facebook Live: loom.ly/nBBponw
📺 YouTube: loom.ly/6CEjtqw
Looking forward to seeing you there!
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY
Join us to hear patients and fibrosis experts from the FIBROTARGET project discuss diagnosis, treatment and new therapeutic innovations!🔬
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET
💻 Register here➡️ loom.ly/6WdjxOY